Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City

References

• Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, Schnabel PA, Eichinger M, Optazaite DE, Puderbach M, et al. 2015. Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol. 10:890–896.
   PubMed Web of Science ®Google Scholar
• Chin J, Syrek Jensen T, Ashby L, Hermansen J, Hutter JD, Conway PH. 2015. Screening for lung cancer with low-dose CT–translating science into Medicare coverage policy. N Engl J Med. 372:2083–2085.
   PubMed Web of Science ®Google Scholar
• Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J, Green BA, Holemans JA, et al. 2016. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax. 71:161–170.
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, et al. 2004. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 9:458–465.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Cancer Collaboration. 2018. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016. JAMA Oncol. doi: 10.1001/jamaoncol.2018.2706.
   Web of Science ®Google Scholar
• Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, et al. 2005. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 47:9–15.
   PubMed Web of Science ®Google Scholar
• The Pulmonary nodules management committee of the Japanese society of CT screening. 2013. Guidelines for the management of pulmonary nodules detected by low dose CT lung cancer screening version 3. [accessed 2018 Sep 26]. http://www.jscts.org/pdf/guideline/gls3rd_english130621.pdf.
   Google Scholar
• Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, et al. 1999. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 354(9173):99–105.
   PubMed Web of Science ®Google Scholar
• Hori M, Tanaka H, Wakai K, Sasazuki S, Katanoda K. 2016. Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies. Jpn J Clin Oncol. 46:942–951.
   PubMed Web of Science ®Google Scholar
• Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, Brambilla G, Angeli E, Aranzulla G, Chiti A, et al. 2015. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med. 191:1166–1175.
   PubMed Web of Science ®Google Scholar
• Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, Moriyama N. 1996. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology. 201:798–802.
   PubMed Web of Science ®Google Scholar
• Kwak N, Park CM, Lee J, Park YS, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Lee CH. 2014. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med. 108:524–530.
   PubMed Web of Science ®Google Scholar
• Martini K, Higashigaito K, Barth BK, Baumueller S, Alkadhi H, Frauenfelder T. 2015. Ultralow-dose CT with tin filtration for detection of solid and sub solid pulmonary nodules: a phantom study. Br J Radiol. 88:20150389.
   PubMed Web of Science ®Google Scholar
• Nakayama T. 2011. Annual survey of CT screening in Japan. JSCTS. 18:127–128. (in-Japanese)
   Google Scholar
• Nawa T, Kusano S, Nakagawa T, Mizoue T, Tachi H, Shimizu K, Yamamoto Y, Hirai S. 2016. CT emphysema constitute a high risk group for future airflow obstruction. Ningen Dock Int. 3:3–6.
   Google Scholar
• Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. 2002. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest. 122:15–20.
   PubMed Web of Science ®Google Scholar
• Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Fukai S, Endo K. 2012. Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening. Lung Cancer. 75:197–202.
   PubMed Web of Science ®Google Scholar
• Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Hayashihara K, Suito T, Endo K. 2012. A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer. 78:225–228.
   PubMed Web of Science ®Google Scholar
• Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, et al. 2011. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 306:1865–1873.
   PubMed Web of Science ®Google Scholar
• Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, et al. 2017. European position statement on lung cancer screening. Lancet Oncol. 18:e754–e766.
   PubMed Web of Science ®Google Scholar
• Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, Pistelli F, Aquilini F, Ocello C, Zappa M, et al. 2017. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 72:825–831.
   PubMed Web of Science ®Google Scholar
• Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, et al. 2012. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 21:308–315.
   PubMed Web of Science ®Google Scholar
• Perisinakis K, Seimenis I, Tzedakis A, Karantanas A, Damilakis J. 2018. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: a phantom study. Eur Radiol. 28:4370–4378.
   PubMed Web of Science ®Google Scholar
• Pinsky PF, Church TR, Izmirlian G, Kramer BS. 2013. The National Lung Screening Trial: results stratified by demographics, smoking history and lung cancer histology. Cancer. 119:3976–3983.
   PubMed Web of Science ®Google Scholar
• Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E. 2015. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 162:485–491.
   PubMed Web of Science ®Google Scholar
• Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, Spaggiari L, Bellomi M. 2017. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 356:j347.
   PubMedGoogle Scholar
• Sagawa M, Nakayama T, Tanaka M, Sakuma T, Sobue T, JECS Study Group. 2012. A randomized controlled trial on the efficacy of thoracic CT screening for lung cancer in non-smokers and smokers of <30 pack-years aged 50–64 years (JECS Study): research design. Jpn J Clin Oncol. 42:1219–1221.
   PubMed Web of Science ®Google Scholar
• Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen KR, et al. 2012. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 67:296–301.
   PubMed Web of Science ®Google Scholar
• Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, Hasegawa M, Yamanda T, Kubo K, Hanamura K, et al. 1998. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 351:1242–1245.
   PubMed Web of Science ®Google Scholar
• Tateno Y, Iinuma T, Matsumoto T, Endo M, Yamamoto S, Matsumoto M 1990. Development of CT scanner for lung cancer screening. Shin-Iryo. 10:28–32. (in Japanese)
   Google Scholar
• The National Lung Screening Trial Research Team. 2011. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 365:395–409.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, Flanders WD, Jee SH, Katanoda K, Kolonel LN, et al. 2008. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med. 5:e185.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. 2017. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 195:557–582.
   PubMed Web of Science ®Google Scholar
• Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, et al. 2017. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax. 72:48–56.
   PubMed Web of Science ®Google Scholar